Article
The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.
International journal of clinical pharmacology and therapeutics - 1 Sept 2015
Zhang Jing-Jing, Liu Shuai-Bing, Xue Ling, Ding Xiao-Liang, Zhang Hua, Miao Li-Yan
Abstract excerpt
PURPOSES: The aims of this study were to assess the influence of the polymorphism of cytochrome P450 oxidoreductase (POR) as well as other relevant genes (CYP3A4, CYP3A5, ABCB1) on individual variability of tacrolimus pharmacokinetics and perform population pharmacokinetic analysis of tacrolimus in Chinese renal transplant recipients. METHODS: Tacrolimus trough whole blood concentrations and clinical details were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
